Ask AI
ProCE Banner Series

Hepatocellular Carcinoma: From Evidence to Treatment Decisions

This educational program will review current and emerging therapies approaches across the hepatocellular carcinoma treatment continuum, with emphasis on evolving efficacy and safety data, liver-function preservation, real-world evidence in patients with poor prognostic features, and practical considerations for treatment selection and the integration of systemic and locoregional therapies.

Key Takeaways

  • Evaluate current and emerging first-line systemic treatment options for patients with unresectable or advanced hepatocellular carcinoma.
  • Incorporate liver function, comorbidities, bleeding risk, and patient characteristics into individualized treatment selection.
  • Assess evidence supporting the integration of systemic and locoregional therapies for selected patients with hepatocellular carcinoma.

All Events

Hepatocellular Carcinoma: From Evidence to Treatment Decisions

Upcoming Events

November

11

2026

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

November

17

2026

12:15 PM - 12:45 PM Pacific Time (PT)

Virtual